Valvular heart disease in patients with Parkinson's disease treated with pergolide. Course following treatment modifications

Journal of Neurology

Volumn 255, Issue 7, 2008, Pages 1045-1048

  Dupuy, D ^a   Lesbre, J P ^a   Gerard P ^a   Andrejak, M ^a   Godefroy, O ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

Echocardiography; Parkinson's disease; Pergolide; Valvular heart disease

Indexed keywords

BROMOCRIPTINE; LEVODOPA; PERGOLIDE;

ADULT; AGED; AORTA VALVE REGURGITATION; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; FRANCE; HUMAN; INCIDENCE; MALE; MITRAL VALVE REGURGITATION; PARKINSON DISEASE; PRIORITY JOURNAL; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID VALVE REGURGITATION; VALVULAR HEART DISEASE;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DOPAMINE AGONISTS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART VALVE DISEASES; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE; ODDS RATIO; PARKINSON DISEASE; PERGOLIDE; RETROSPECTIVE STUDIES;

EID: 50049120768     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-008-0839-1     Document Type: Article

References (18)

1. Van Camp 2004 Lancet 363 1179
2. Pritchett 2002 Mayo Clin Proc 77 1280
3. Van Camp 2003 Neurology 61 859
4. Baseman 2004 Neurology 27 301
5. Waller 2005 Mayo Clin Proc 80 1016
6. Zadikoff 2006 Can J Neurol Sci 33 27
7. Peralta 2006 Mov Disord 21 1109
8. Serratrice 2002 Cardiol Rev 10 334
9. Ruzicka 2007 J Neurol 254 1575
10. Zoghbi 2003 J Am Soc Echocardiogr 16 777
11. Shaunak 1999 J Neurosurg Psychiatry 66 79
12. Flowers 2003 Mayo Clin Proc 78 730
13. FDA (2003) 2003 Safety Alert-Permax (pergolide mesylate) (http:mermax.htm/www.fda.gov/medwatch/SAFETY/2003)
14. Kim 2006 Mov Disord 21 126
15. Yamamoto 2006 Neurology 67 1225
16. Zanettini 2007 N Engl J Med 356 39
17. Schade 2007 N Engl J Med 356 29
18. Horvath 2004 Mov Disord 19 656